Rapid Micro Biosystems, Inc. (RPID) Misses Q4 EPS by 1c ; Offers Guidance

Rapid Micro Biosystems, Inc. (NASDAQ: RPID) reported Q4 EPS of ($0.22), $0.01 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $8.2 million versus the consensus estimate of $7.8 million.

GUIDANCE:

Rapid Micro Biosystems, Inc. sees FY2025 revenue of ~$32 million, versus the consensus of $32.9 million.

For earnings history and earnings-related data on Rapid Micro Biosystems, Inc. (RPID) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Lockheed Martin wins $2.8B in Defense contracts for F-35, helicopters
• Adobe Systems (ADBE) Tops Q2 EPS by 14c, Offers Guidance